Wide Ranks

KLTOW

0.0256

Top Statistics
Market Cap 0.0000 Forward PE 0.0000 Revenue Growth 0.00 %
Current Ratio 1.11 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 845336 Total Cash Per Share 0.0400 Total Debt 3 M
Total Debt To Equity Current Ratio 1.11 Book Value Per Share 0.0010
All Measures
Message Board Id finmb_36437530 City Omaha Uuid 1a828e17-ee55-3e02-8262-8bee32807742
Previous Close 0.0230 Book Value 0.0010 Beta 0.0560
Total Debt 3 M Volume 1720 Price To Book 25.60
Fifty Two Week Low 0.0256 Total Cash Per Share 0.0400 Max Age 86400
Sand P52 Week Change 0.3133 Net Income To Common -1394269 Trailing Peg Ratio None
Total Cash 845336 Trailing PE 0.0000 Regular Market Previous Close 0.0230
Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000 Open 0.0373
Free Cashflow -168167 State NE Dividend Yield 0.00 %
Return On Assets -0.2357 Time Zone Short Name EST Day Low 0.0256
Address1 13576 Walnut Street Target High Price 0.0000 Price Hint 4
Website https://www.klothoneuro.com Forward Eps 0.0000 Recommendation Key none
Compensation As Of Epoch Date 1 B Quick Ratio 94.10 % Is_sp_500 False
Regular Market Day High 0.0373 Profit Margins 0.00 % Fifty Two Week High 0.0373
Day High 0.0373 Regular Market Open 0.0373 Industry Key biotechnology
Earnings Growth 0.00 % Revenue Growth 0.00 % Operating Cashflow -1134886
Currency USD Time Zone Full Name America/New_York Is_nasdaq_100 False
Market Cap 0.0000 Zip 68144 Quote Type EQUITY
Industry Biotechnology Long Name Klotho Neurosciences, Inc. Regular Market Day Low 0.0256
Current Price 0.0256 Address2 Suite A Financial Currency USD
Current Ratio 1.11 Industry Disp Biotechnology Country United States
Float Shares 9 M Forward PE 0.0000 Regular Market Volume 1720
Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics.

Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors.

The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases.

The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024.

Klotho Neurosciences, Inc. is based in Omaha, Nebraska.